Panax, Kubala, Ryznarsp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-05-06
Registered address
ul. 700-Lecia Strzyżowa 4, 38-100 Strzyżów, Poland
Electronic delivery address
AE:PL-71385-52032-VSETS-09

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements not filed.

  • 202509/06/2026
  • 202402/07/2025
  • 202328/06/2024
  • 202206/04/2023
  • 202109/06/2022
  • 2020not filed
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 54%
Division · Retail trade3,751 / 9,913
Top 38%
City · Strzyżów12 / 60
Top 20%
Voivodeship · Podkarpackie2,306 / 10,815
Top 21%
Country · Poland62,588 / 297,935
Top 21%

Results vs industry

Revenue
This companyUSD 1.92mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 33.28kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 1.87mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 305.42kMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Panax, Kubala, Ryznar has been an NFZ healthcare provider since 2008. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciespodkarpackie1USD 0.00

Ownership

Manner of representation

Each partner is authorised to make declarations of will on behalf of the company individually.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1993-07-05.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

7 public aid cases recorded, with a total value of $98,713.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,274
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,281
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,376

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Herbarium Świętego Franciszkasp. z o.o.
Eurekasp. z o.o.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Twoja Tania Apteka Farmarsp. z o.o.

Change history

DateEvent
2018-09-10Address change
2007-10-03Name change
2002-05-06Entered in the register

FAQ

Last updated: 2026-06-09